苯并咪唑衍生物作为新型抗帕金森病药物的潜力
Neda Anastassova, Denitsa Aluani, Anton Kostadinov, Miroslav Rangelov, Nadezhda Todorova, Nadya Hristova-Avakumova, Maria Argirova, Nikolay Lumov, Magdalena Kondeva-Burdina, Virginia Tzankova, Denitsa Yancheva. Evaluation of the combined activity of benzimidazole arylhydrazones as new anti-Parkinsonian agents: monoamine oxidase-B inhibition, neuroprotection and oxidative stress modulation[J]. Neural Regeneration Research, 2021, 16(11):
2299-2309. doi: 10.4103/1673-5374.309843
摘要
(
125 )
PDF(3318KB)
(
107
)
引言 |
材料方法 |
结果 |
讨论 |
文章快阅 |
延伸阅读 |
手机杂志 |
点击(
125 ) | 下载(
107
) |
多维度评价 |
文章评价 |
相关文章
|